IRIS UniCatt

Tumbarello, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.918
NA - Nord America 9.665
AS - Asia 7.586
SA - Sud America 1.477
AF - Africa 188
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 28.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.430
DE - Germania 4.160
SG - Singapore 3.162
CN - Cina 2.789
BR - Brasile 1.220
SE - Svezia 1.220
IT - Italia 896
UA - Ucraina 840
FR - Francia 602
PL - Polonia 548
GB - Regno Unito 432
IE - Irlanda 367
VN - Vietnam 293
FI - Finlandia 264
IN - India 263
TR - Turchia 261
ID - Indonesia 253
RU - Federazione Russa 208
HK - Hong Kong 105
AR - Argentina 104
CA - Canada 103
BD - Bangladesh 88
MX - Messico 86
JP - Giappone 58
ZA - Sudafrica 57
AT - Austria 55
BE - Belgio 52
IQ - Iraq 52
NL - Olanda 50
ES - Italia 49
EC - Ecuador 38
MA - Marocco 35
CO - Colombia 30
IR - Iran 26
PK - Pakistan 24
VE - Venezuela 24
SA - Arabia Saudita 23
IL - Israele 22
RO - Romania 21
KR - Corea 19
UZ - Uzbekistan 19
CH - Svizzera 18
AE - Emirati Arabi Uniti 17
EG - Egitto 17
LT - Lituania 17
AU - Australia 16
JO - Giordania 16
UY - Uruguay 15
CZ - Repubblica Ceca 14
TN - Tunisia 14
GR - Grecia 13
KE - Kenya 13
PE - Perù 13
PH - Filippine 13
CL - Cile 12
EU - Europa 12
BG - Bulgaria 11
BO - Bolivia 10
KZ - Kazakistan 10
AL - Albania 9
CI - Costa d'Avorio 9
ET - Etiopia 9
HU - Ungheria 9
LV - Lettonia 8
NP - Nepal 8
PT - Portogallo 8
PY - Paraguay 8
AZ - Azerbaigian 7
BZ - Belize 7
HN - Honduras 7
JM - Giamaica 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
NG - Nigeria 6
CR - Costa Rica 5
HR - Croazia 5
MD - Moldavia 5
MY - Malesia 5
NO - Norvegia 5
OM - Oman 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
VA - Santa Sede (Città del Vaticano) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
EE - Estonia 3
GE - Georgia 3
LB - Libano 3
MU - Mauritius 3
PA - Panama 3
RE - Reunion 3
SN - Senegal 3
Totale 28.819
Salva come PNG Salva come JPEG
Città #
Chandler 1.512
Singapore 1.353
Ashburn 833
Hangzhou 621
Jacksonville 573
Warsaw 428
Beijing 420
San Mateo 398
Nanjing 376
Dublin 362
Ann Arbor 355
Dearborn 301
Woodbridge 267
Nürnberg 266
Wilmington 265
New York 250
Jakarta 234
Los Angeles 225
Izmir 207
Houston 194
Boston 176
Munich 163
Hefei 159
Lawrence 140
Milan 139
Fairfield 138
Moscow 136
Seattle 136
Nanchang 127
Cattolica 123
São Paulo 121
Marseille 119
Ho Chi Minh City 108
Kraków 104
Redwood City 104
Hong Kong 102
Chicago 99
Buffalo 91
Frankfurt am Main 87
Rome 87
Princeton 80
The Dalles 78
Shenyang 73
Guangzhou 70
Kunming 70
Dallas 68
Bremen 65
Tianjin 65
Hanoi 63
Mountain View 62
Hebei 61
Boardman 59
Lancaster 58
Norwalk 53
Brussels 52
Zhengzhou 51
Helsinki 48
University Park 47
London 45
Brooklyn 43
Cambridge 43
Tokyo 42
Jiaxing 41
Redmond 40
Santa Clara 40
Changsha 39
Falls Church 36
Kent 36
Rio de Janeiro 34
Vienna 34
Toronto 33
Fremont 31
Jinan 31
Pune 31
Montreal 29
Nuremberg 29
Phoenix 29
Leawood 28
San Francisco 27
Belo Horizonte 26
Johannesburg 26
Shanghai 25
San Jose 24
Augusta 22
Chennai 22
Paris 22
Baghdad 21
Brasília 21
Campinas 21
Lanzhou 21
Stockholm 21
Turku 21
Düsseldorf 20
Hyderabad 20
Ningbo 20
Auburn Hills 19
Denver 19
Dhaka 19
Mexico City 19
Atlanta 18
Totale 14.210
Salva come PNG Salva come JPEG
Nome #
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 368
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 346
Factors associated with mortality in bacteremic patients with hematologic malignancies. 345
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 343
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 337
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 296
A prospective survey of febrile events in hematological malignancies 289
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 285
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 285
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 275
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 266
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 262
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 255
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 233
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 231
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 229
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 226
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 217
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 207
Factors associated with mortality in bacteremic patients with hematologic malignancies. 205
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 204
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 198
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 198
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 187
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 185
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 180
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 178
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 177
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 172
Safety and effectiveness of transvenous lead extraction in octogenarians 171
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 171
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 169
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 168
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 168
Whole-genome sequencing reveals host factors underlying critical COVID-19 167
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 167
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 166
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 165
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 163
Neurological involvement during legionellosis, look beyond the lung 162
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 160
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 159
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 158
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 157
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 157
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 156
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 155
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 153
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 153
Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 153
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 152
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 151
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 151
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 149
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 149
Attitudes and practices of dentists treating HIV patients in HAART era. 147
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 147
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 146
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 145
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 142
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 142
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 139
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 139
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 138
Oral lesions in HIV and HCV co-infected individuals in HAART era 138
A prospective survey of febrile events in hematological malignancies 137
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 136
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 135
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 134
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 134
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 134
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 134
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 134
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 133
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 132
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 132
Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey 131
A prospective survey of febrile events in hematological malignancies 130
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 130
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 129
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 129
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 128
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 127
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 127
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 127
An explainable model of host genetic interactions linked to COVID-19 severity 126
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART. 126
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 125
Neurological involvement during Legionellosis, look beyond the lung 125
Oral lesions in HIV and HCV co-infected individuals in HAART era 124
Meningoencephalomyelitis caused by herpes simplex virus-1 in a patient with idiopathic T CD4+ lymphocytopenia. 123
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. 123
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 122
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 122
Mortality in patients with early- or late-onset candidaemia 122
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 122
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 122
Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. 121
Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognostic indicators 121
Totale 17.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.082 0 0 0 0 0 106 193 58 285 68 310 62
2021/20222.069 194 189 63 114 117 110 37 360 90 133 264 398
2022/20234.027 472 553 312 575 286 512 174 316 490 121 151 65
2023/20241.755 107 578 45 82 53 224 105 73 27 58 172 231
2024/20253.784 116 131 286 139 391 116 122 201 606 326 715 635
2025/20265.666 1.571 279 514 1.071 1.902 329 0 0 0 0 0 0
Totale 29.110